argenx SE
first in class antagonist patients on drug for more than years | argenx SE
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
5 of 20
Similar slides by argenx SE
See diffirences between slides (animation)
Results
May 2021
first in class antagonist patients on drug for more than years | argenx SE
Related slides by other companies
Absci
Investor Presentation
October 2023
what if the next transformative drug was not discovered but created with a click of a button | Absci
Exscientia
Investor Presentation
October 2023
solution integrating knowledge of the patient and drug precision medicine | Exscientia
Exscientia
Investor Presentation
November 2023
solution integrating knowledge of the patient and drug precision medicine | Exscientia
AbCellera
IPO
December 2020
cro drug development fails too often mele seme a ted to years of rate ory drug development average antibody forester tech access impact drug developers focus on getting one result is drug candidate to the finish line the a chronic in the technologies to make the process of drug development better | AbCellera
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io